The genetic control of human Ia alloantigens: a three-loci model derived from the immunochemical analysis of 'supertypic' specificities.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001666:Binding Sites, Antibody / Q000187:drug effects / Q000235:genetics; D055598:Chemical Phenomena; D002621:Chemistry; D002627:Chemistry, Physical; D002874:Chromosome Mapping; D003429:Cross Reactions; D003601:Cytotoxicity Tests, Immunologic; D000939:Epitopes / Q000032:analysis* / Q000235:genetics; D005802:Genes, MHC Class II; D008040:Genetic Linkage; D006684:HLA-DR Antigens; D015804:HLA-DR4 Antigen; D015809:HLA-DR7 Antigen; D000949:Histocompatibility Antigens Class II / Q000032:analysis / Q000276:immunology; D006801:Humans; D008954:Models, Biological; D010206:Papain / Q000494:pharmacology; D011817:Rabbits
D000961:Antilymphocyte Serum; D000939:Epitopes; D006684:HLA-DR Antigens; D015804:HLA-DR4 Antigen; D015809:HLA-DR7 Antigen; D000949:Histocompatibility Antigens Class II; D010206:Papain